Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Dermatology

  Free Subscription


26.02.2024

3 Am J Dermatopathol
1 Am J Pathol
1 Ann Intern Med
4 BMC Cancer
28 Br J Dermatol
6 Cancer
4 Clin Dermatol
19 Clin Exp Dermatol
23 Int J Dermatol
1 Intern Med
14 J Dermatol
5 J Invest Dermatol
2 J Laryngol Otol
4 Lancet
3 Mycoses
3 N Engl J Med
11 Plast Reconstr Surg
6 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Dermatopathol

  1. DASH S, Behera B, Viswan P, Garg K, et al
    Rapidly Progressive and Debilitating Epithelioid Hemangioendothelioma: An Atypical Presentation of a Rare Malignant Cutaneous Vascular Neoplasm.
    Am J Dermatopathol. 2024 Feb 7. doi: 10.1097/DAD.0000000000002625.
    PubMed         Abstract available

  2. MACHUCA-AGUADO J, Garcia-Trevijano CI, Orrego-Pereira C, Montana-Ramirez AM, et al
    Unraveling PRAME Expression in Desmoplastic Melanocytic Neoplasms: Illuminating its Diagnostic Significance in Distinguishing Desmoplastic Spitz Nevi.
    Am J Dermatopathol. 2024 Feb 7. doi: 10.1097/DAD.0000000000002638.
    PubMed        

  3. HABERECHT H, Tekin B, Warren K, Guo RR, et al
    Cutaneous Malignant Mixed Tumor With Pulmonary Metastasis: A Case Report and Literature Review.
    Am J Dermatopathol. 2024 Feb 7. doi: 10.1097/DAD.0000000000002629.
    PubMed         Abstract available


    Am J Pathol

  4. AYANA G, Lee E, Choe SW
    Vision transformers for breast cancer human epidermal growth factor receptor 2 (HER2) expression staging without immunohistochemical (IHC) staining.
    Am J Pathol. 2023 Dec 12:S0002-9440(23)00460.
    PubMed         Abstract available


    Ann Intern Med

  5. TANNER M
    In women aged 45 to 75 y, opt-out vs. opt-in breast cancer screening outreach did not increase mammography rates.
    Ann Intern Med. 2024;177:JC20.
    PubMed         Abstract available


    BMC Cancer

  6. ABEDI M, Sahebi L, Eslami B, Saberi A, et al
    Using a combination of superb microvascular imaging and other auxiliary ultrasound techniques to increase the accuracy of gray-scale ultrasound for breast masses.
    BMC Cancer. 2024;24:224.
    PubMed         Abstract available

  7. BEN-ZION BERLINER M, Yust-Katz S, Lavie I, Goldberg Y, et al
    Central nervous system metastases in breast cancer patients with germline BRCA pathogenic variants compared to non-carriers: a matched-pair analysis.
    BMC Cancer. 2024;24:219.
    PubMed         Abstract available

  8. LABEDZ N, Anisiewicz A, Stachowicz-Suhs M, Banach J, et al
    Dual effect of vitamin D(3) on breast cancer-associated fibroblasts.
    BMC Cancer. 2024;24:209.
    PubMed         Abstract available

  9. ZHANG Y, Song M, Yang Z, Huang X, et al
    Healthy lifestyles, systemic inflammation and breast cancer risk: a mediation analysis.
    BMC Cancer. 2024;24:208.
    PubMed         Abstract available


    Br J Dermatol


  10. Alopecia areata and comorbidities associated with it in Germany.
    Br J Dermatol. 2024;190:e32.
    PubMed        


  11. Macrophages dampen skin inflammation after stem cell transplantation.
    Br J Dermatol. 2024;190:e35.
    PubMed        


  12. Safety of combination therapy for psoriasis: findings from the BIOBADADERM registry.
    Br J Dermatol. 2024;190:e30.
    PubMed        


  13. Comorbidities in people with psoriasis.
    Br J Dermatol. 2024;190:e31.
    PubMed        


  14. A clinical trial investigating if antibacterial therapeutic clothing could improve atopic dermatitis.
    Br J Dermatol. 2024;190:e29.
    PubMed        


  15. A review of the role of the NLRP1 inflammasome in skin conditions.
    Br J Dermatol. 2024;190:e27.
    PubMed        


  16. Greater understanding about the role of a long non-coding RNA in the development of cutaneous squamous cell carcinoma.
    Br J Dermatol. 2024;190:e36.
    PubMed        


  17. Results from the Treatment of Hidradenitis Suppurativa Evaluation Study (THESEUS).
    Br J Dermatol. 2024;190:e33.
    PubMed        


  18. Outcomes that need to be assessed in pyoderma gangrenosum clinical trials.
    Br J Dermatol. 2024;190:e34.
    PubMed        

  19. ALABAS OA, Yiu ZZN
    A sprinkle of methotrexate to go with biologics: a safe recipe?
    Br J Dermatol. 2024;190:302-303.
    PubMed        

  20. LIU Y, Mo R, Chen Z, Yang Y, et al
    Novel variants in ABCA12 cause erythrokeratodermia variabilis.
    Br J Dermatol. 2024;190:454.
    PubMed        

  21. HOPKINS ZH, Chada LMP, Duffin KC
    Defining what matters through core outcomes set development: uniting stakeholder perspectives, empowering patient voices.
    Br J Dermatol. 2024;190:301-302.
    PubMed        

  22. BREHON A, Bensefa-Colas L, D'Andrea C, Jeziorski E, et al
    Guidelines for cold urticaria management established by the Centre of Evidence of Dermatology and the Urticaria Group of the French Society of Dermatology.
    Br J Dermatol. 2024;190:445-447.
    PubMed        

  23. JACOBSON ME, Rick JW, Gerbens LAA, Baghoomian W, et al
    A core domain set for pyoderma gangrenosum trial outcomes: an international eDelphi and consensus study from the UPGRADE initiative.
    Br J Dermatol. 2024;190:392-401.
    PubMed         Abstract available

  24. KINOSHITA-ISE M
    Updated epidemiology of alopecia areata in Germany: the data tell a lot but hide a lot.
    Br J Dermatol. 2024;190:297-298.
    PubMed        

  25. JUNG JM, Cho HS, Kim GH, Won CH, et al
    Psoriasiform mycosis fungoides: a clinical and prognostic retrospective cohort study.
    Br J Dermatol. 2024;190:432-434.
    PubMed        

  26. AUGUSTIN M, Ben-Anaya N, Muller K, Hagenstrom K, et al
    Epidemiology of alopecia areata and population-wide comorbidities in Germany: analysis of longitudinal claims data.
    Br J Dermatol. 2024;190:374-381.
    PubMed         Abstract available

  27. INGRAM JR, Bates J, Cannings-John R, Collier F, et al
    Treatment of Hidradenitis Suppurativa Evaluation Study (THESEUS): a prospective cohort study.
    Br J Dermatol. 2024;190:382-391.
    PubMed         Abstract available

  28. GARG A, Mastacouris N, Ingram JR, Strunk A, et al
    Addressing high placebo response rates in randomized clinical trials for hidradenitis suppurativa.
    Br J Dermatol. 2024;190:427-429.
    PubMed        

  29. VYAS J, Johns JR, Ali FM, Singh RK, et al
    A systematic review of 454 randomized controlled trials using the Dermatology Life Quality Index: experience in 69 diseases and 43 countries.
    Br J Dermatol. 2024;190:315-339.
    PubMed         Abstract available

  30. STAMMLER R, Ta VA, Cohen E, Ram-Wolff C, et al
    Failure of second challenge with Mogamulizumab in CCR4-positive cutaneous T-cell lymphoma.
    Br J Dermatol. 2024 Feb 23:ljae085. doi: 10.1093.
    PubMed        

  31. HUGHES O, Thompson AR
    Dealing with Flares in Skin Conditions: How Can We Meet Patient Need?
    Br J Dermatol. 2024 Feb 23:ljae084. doi: 10.1093.
    PubMed        


  32. Correction to: How to recognize and manage skin toxicities associated with immune checkpoint inhibitors: a practical approach.
    Br J Dermatol. 2024 Feb 21:ljae060. doi: 10.1093.
    PubMed        

  33. JARIWALA N, Ozols M, Eckersley A, Mambwe B, et al
    Prediction, screening and characterization of novel bioactive tetra-peptide matrikines for skin rejuvenation.
    Br J Dermatol. 2024 Feb 20:ljae061. doi: 10.1093.
    PubMed         Abstract available

  34. GLEESON D, Naveed M, Moorhead L, McAteer H, et al
    Acceptability of 'as needed' biologic therapy in psoriasis: insights from a multi-stakeholder mixed methods study.
    Br J Dermatol. 2024 Feb 17:ljae068. doi: 10.1093.
    PubMed         Abstract available

  35. BABAKINEJAD P, Lapsley R, Forster L, McPherson S, et al
    Cumulative methotrexate dose is not associated with liver fibrosis in patients with a history of moderate to severe psoriasis.
    Br J Dermatol. 2024 Feb 17:ljae069. doi: 10.1093.
    PubMed         Abstract available

  36. CAI L, Jiang C, Zhang G, Fang H, et al
    A multicenter, randomized, double-blinded, placebo-controlled, phase ? study evaluating the efficacy and safety of Xeligekimab (GR1501) in patients with moderate-to-severe plaque psoriasis.
    Br J Dermatol. 2024 Feb 15:ljae062. doi: 10.1093.
    PubMed         Abstract available

  37. WAN G, Khattab S, Leung BW, Zhang S, et al
    Cancer Type and Histology Influence Cutaneous Immunotherapy Toxicities: A Multi-Institutional Cohort Study.
    Br J Dermatol. 2024 Feb 15:ljae053. doi: 10.1093.
    PubMed         Abstract available


    Cancer

  38. GALI K, Orban E, Ozga AK, Mohl A, et al
    Does breast cancer modify the long-term relationship between lifestyle behaviors and mortality? A prospective analysis of breast cancer survivors and population-based controls.
    Cancer. 2023 Nov 11. doi: 10.1002/cncr.35104.
    PubMed         Abstract available

  39. ROSENBERG SM, McCue S, He J, Lafky JM, et al
    Alliance A151945: Accrual and characteristics of adolescent and young adult patients in Alliance trials from 2000 to 2017.
    Cancer. 2024;130:750-769.
    PubMed         Abstract available

  40. GORDON MJ, Feng L, Strati P, Lee HJ, et al
    Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma: An open label, phase 2 study.
    Cancer. 2023 Nov 20. doi: 10.1002/cncr.35114.
    PubMed         Abstract available

  41. OZTEKIN S, Hooning MJ, van Deurzen CHM, Dietvorst AHP, et al
    The effect of (neo)adjuvant chemotherapy on long-term survival outcomes in patients with invasive lobular breast cancer treated with endocrine therapy: A retrospective cohort study.
    Cancer. 2023 Nov 20. doi: 10.1002/cncr.35125.
    PubMed         Abstract available

  42. JI J, Bae M, Sun CL, Wildes TM, et al
    Falls prechemotherapy and toxicity-related hospitalization during adjuvant chemotherapy for breast cancer in older women: Results from the prospective multicenter HOPE trial.
    Cancer. 2023 Nov 14. doi: 10.1002/cncr.35105.
    PubMed         Abstract available

  43. LIN M, Luo T, Jin Y, Zhong X, et al
    HER2-low heterogeneity between primary and paired recurrent/metastatic breast cancer: Implications in treatment and prognosis.
    Cancer. 2023 Nov 7. doi: 10.1002/cncr.35101.
    PubMed         Abstract available


    Clin Dermatol

  44. TAHIR A, Khan S, Shah RR, Waqas N, et al
    Efficacy of combined spironolactone and topical retinoids in South Asian women with acne.
    Clin Dermatol. 2024;42:89-90.
    PubMed        

  45. MOOSVI N, Kovarik C
    Readability, accuracy, and appropriateness of ChatGPT 4.0 responses for use in patient education materials for Condyloma acuminatum.
    Clin Dermatol. 2024;42:87-88.
    PubMed        

  46. KIM HJ, Kim E, Yook HJ, Bang CH, et al
    Ingrown nail correction device using three-dimensionally printed thermoplastic polyurethane and nickel-titanium shape-memory alloy.
    Clin Dermatol. 2024;42:84-86.
    PubMed        

  47. SANTIAGO S, Enwereji N, Jiang C, Durrani K, et al
    Ocular and eyelid involvement in collagen vascular diseases. Part II. Dermatomyositis, scleroderma, and sarcoidosis.
    Clin Dermatol. 2024;42:9-16.
    PubMed         Abstract available


    Clin Exp Dermatol

  48. ALTUNISIK N
    Comment on 'Dramatic improvement with colchicine in antihistamine- and omalizumab-resistant chronic spontaneous urticaria'.
    Clin Exp Dermatol. 2024;49:289.
    PubMed        

  49. KARPONIS D, Stratigos IA, Joshy J, Craig PJ, et al
    Lentigo maligna: a review.
    Clin Exp Dermatol. 2024;49:218-225.
    PubMed         Abstract available

  50. HOUSSET M, Dessertenne G, Marchand E, Daligault M, et al
    A multicentre retrospective study of lumbar sympathectomy for plantar hyperhidrosis: satisfaction and postoperative complications.
    Clin Exp Dermatol. 2024;49:241-246.
    PubMed         Abstract available

  51. MAJTANOVA N, Kolar P, Takacova A, Kurilova V, et al
    Xenograft: a suitable treatment of eyelid complications in long-standing necrobiotic xanthogranuloma.
    Clin Exp Dermatol. 2024;49:280-282.
    PubMed        

  52. MOSS C, Haider Z, Proctor A
    Do people with eczema and their carers understand topical steroid potency? Results of two surveys.
    Clin Exp Dermatol. 2024;49:267-270.
    PubMed         Abstract available

  53. BINNS HM, Tasker F, Lewis FM
    Drug eruptions and the vulva.
    Clin Exp Dermatol. 2024;49:211-217.
    PubMed         Abstract available

  54. AGBARA IC, Nnaji TO, Enechukwu NA, Emeka CM, et al
    Navigating diagnostic challenges in syphilitic alopecia: insights from dermoscopy.
    Clin Exp Dermatol. 2024;49:273-275.
    PubMed        

  55. TANIGASSALAME P, Murthy AB, Palaniappan V, Karthikeyan K, et al
    Kindler syndrome with a novel mutation and gynaecological complication.
    Clin Exp Dermatol. 2024;49:302-305.
    PubMed        

  56. LAU WC, Yang K, Lau CB, Patel S, et al
    Characterization of sun-protective behaviours among Asian people in the USA stratified by geographic location of birth.
    Clin Exp Dermatol. 2024;49:282-284.
    PubMed        

  57. ACOS RLC, Chang YH, Lin YC, Salazar-Paras DKR, et al
    Variable clinical consequences of mosaicism for c.1167dupC in IKBKG in male and female patients with incontinentia pigmenti and related phenotypes.
    Clin Exp Dermatol. 2024;49:298-301.
    PubMed        

  58. CHEN L, Wang Y, Gao X, Li Q, et al
    Reflectance confocal microscopy as a complementary diagnostic tool for greyish-brown dermatoses in children.
    Clin Exp Dermatol. 2024;49:259-262.
    PubMed         Abstract available

  59. KUMAR JINDAL A, Sil A, Aggarwal R, Tyagi R, et al
    Clinical, immunological and molecular profiles of DOCK8 deficiency in six patients from a tertiary care centre in North India.
    Clin Exp Dermatol. 2024;49:226-234.
    PubMed         Abstract available

  60. GOOLAMALI SI, Shim TN, Purdie K, Mladkova N, et al
    Is the presence of Merkel cell polyomavirus and human papillomavirus DNA in keratinocyte cancers and precancers associated with HIV status? A case-control study.
    Clin Exp Dermatol. 2024;49:263-266.
    PubMed         Abstract available

  61. MARTINS F, Ramalho AR, Flor D, Batista M, et al
    Painful subcutaneous masses in a patient with severe psoriasis.
    Clin Exp Dermatol. 2024 Feb 23:llae064. doi: 10.1093.
    PubMed        

  62. TAN S, Hu H, Li G, Zhao J, et al
    Prevalence, incidence density and standardized morbidity rate of melanoma among patients with congenital melanocytic nevi: A systematic review.
    Clin Exp Dermatol. 2024 Feb 21:llae056. doi: 10.1093.
    PubMed         Abstract available

  63. JUAN-CARPENA G, Martinez Banaclocha N, Palazon-Cabanes JC, Niveiro-de Jaime M, et al
    Cutaneous immune-related adverse events: incidence rates, risk factors and association with extracutaneous toxicity. A prospective study of 189 patients treated with checkpoint inhibitors in a Spanish tertiary care hospital.
    Clin Exp Dermatol. 2024 Feb 19:llae060. doi: 10.1093.
    PubMed         Abstract available

  64. DIAZ MJ, Haq Z, Abdi P, Tran JT, et al
    A propensity-matched study of psoriasis and migraine in a nationally representative cohort.
    Clin Exp Dermatol. 2024 Feb 19:llae059. doi: 10.1093.
    PubMed        

  65. MANN N, Cunliffe A, Levell N, Bleiker T, et al
    A Superclinic model for tackling skin cancer referrals.
    Clin Exp Dermatol. 2024 Feb 14:llae051. doi: 10.1093.
    PubMed        

  66. GROVER S, Patel N, Tso S
    The relative carbon footprint differences between NICE melanoma follow-up pathways 2015 and 2022.
    Clin Exp Dermatol. 2024 Feb 12:llae043. doi: 10.1093.
    PubMed        


    Int J Dermatol

  67. VERMA V, Chandra AD, Mehta N, Verma KK, et al
    Nicolau syndrome postintramuscular diclofenac injection: preventable iatrogenic error or an unfortunate sequalae?
    Int J Dermatol. 2024;63:396-398.
    PubMed        

  68. KUMAR S, Bains A, Patra S, Rao M, et al
    Unilateral lower limb ulcers mimicking medium vessel vasculitis in two patients of aortoiliac occlusive disease.
    Int J Dermatol. 2024;63:393-395.
    PubMed        

  69. HRIN ML, Oscherwitz M, Jorizzo JL, Feldman SR, et al
    Evaluation of pentoxifylline in the treatment of necrobiosis lipoidica: outcomes in 10 patients.
    Int J Dermatol. 2024;63:390-392.
    PubMed        

  70. TYAGI M, Verma V, Bhari N, Gupta S, et al
    Herpes presenting as pyoderma gangrenosum-like ulcers in a child with AIDS.
    Int J Dermatol. 2024;63:371-373.
    PubMed        

  71. VALTELLINI L, Barei F, Zussino M, Marzano AV, et al
    Dupilumab: a new frontier for chronic urticaria. A case series and review of the literature.
    Int J Dermatol. 2024;63:399-401.
    PubMed        

  72. PENG Y, Wang B, Mao M, Li J, et al
    Clinical characteristics of the well-defined upper eyelid vascular network pattern in patients with rosacea.
    Int J Dermatol. 2024;63:337-344.
    PubMed         Abstract available

  73. SENSOZ S, Bilgener E, Mumcuoglu KY, Taylan-Ozkan A, et al
    Pediculicide regulations and usage trends in Turkiye in 2015-2022.
    Int J Dermatol. 2024;63:359-367.
    PubMed         Abstract available

  74. DEMIR G, Aksoy F, Bugdayci O, Kaptanoglu AF, et al
    Elastography findings in acne scar patients who were treated with microneedling.
    Int J Dermatol. 2024;63:330-336.
    PubMed         Abstract available

  75. JOSHI TP, Tran T, Kelly BC
    Association of granuloma annulare with dyslipidemia, hypertension, and type 2 diabetes mellitus: a systematic review and meta-analysis.
    Int J Dermatol. 2024;63:376-378.
    PubMed        

  76. TOD B, Whitaker D, Visser W, Isaacs T, et al
    Integrated sun protection advice for the South African population.
    Int J Dermatol. 2024;63:277-287.
    PubMed         Abstract available

  77. PATRO N, Sathishkumar D, Panda M, Mahajan R, et al
    Algorithmic approach toward diagnosis of patients with congenital photosensitivity disorders and review of literature.
    Int J Dermatol. 2024;63:298-305.
    PubMed         Abstract available

  78. CHEN GF, Cohen JM, Eisenstein A
    Associations between hidradenitis suppurativa and asthma and allergic rhinitis: a case-control study in the All of Us research program.
    Int J Dermatol. 2024;63:e74-e75.
    PubMed        

  79. SCHNEIDER JG, Gallardo M, Fisher K, Kaffenberger BH, et al
    Increased mortality among African American patients with DRESS syndrome compared to White patients.
    Int J Dermatol. 2024;63:e80-e81.
    PubMed        

  80. LARA MOYA A, Lopez-Llunell C, Saez Artacho E
    Nodular pigmented lesion on the cheek.
    Int J Dermatol. 2024;63:311-312.
    PubMed        

  81. SLAVINSKY V, Helmy J, Vroman J, Valdebran M, et al
    Solar ultraviolet radiation exposure in workers with outdoor occupations: a systematic review and call to action.
    Int J Dermatol. 2024;63:288-297.
    PubMed         Abstract available

  82. MONTEIRO RC, Fernandes M
    Are antibiotics still relevant in acne? A review of the therapeutic conundrum.
    Int J Dermatol. 2024;63:306-310.
    PubMed         Abstract available

  83. DE FAVERNEY PM, Molamodi K, Tancrede-Bohin E, Verschoore M, et al
    Support for dermatological research in Sub-Saharan Africa: insights from African hair and skin research programs.
    Int J Dermatol. 2024 Feb 17. doi: 10.1111/ijd.17058.
    PubMed         Abstract available

  84. LUO SY, Zhou KY, Wang QX, Deng LJ, et al
    Atypical plaque psoriasis: a clinicopathological study of 20 cases.
    Int J Dermatol. 2024 Feb 17. doi: 10.1111/ijd.17063.
    PubMed         Abstract available

  85. WONDIMU B, Sokumbi O
    What can we learn about skin of color in dermatopathology?
    Int J Dermatol. 2024 Feb 15. doi: 10.1111/ijd.17048.
    PubMed         Abstract available

  86. VENTURI F, Lambertini M, Melotti B, De Paolis M, et al
    Effective management of infiltrative locally advanced basal cell carcinoma of the tibia with sonidegib.
    Int J Dermatol. 2024 Feb 13. doi: 10.1111/ijd.17083.
    PubMed        

  87. DINI F, Susini P, Nisi G, Cuomo R, et al
    Periocular sebaceous carcinoma: updates in the diagnosis, treatment, staging, and management.
    Int J Dermatol. 2024 Feb 13. doi: 10.1111/ijd.17045.
    PubMed         Abstract available

  88. CHEN X, Deng G, Chen K, Chen Y, et al
    Targeting the NLRP3 inflammasome in psoriasis.
    Int J Dermatol. 2024 Feb 12. doi: 10.1111/ijd.17073.
    PubMed         Abstract available

  89. GOLDUST M
    Progress and challenges of artificial intelligence in skin of color.
    Int J Dermatol. 2024 Feb 12. doi: 10.1111/ijd.17071.
    PubMed        


    Intern Med

  90. TANAKA Y, Kobayashi T, Shimizu S, Kurahara Y, et al
    Cutaneous Leukocytoclastic Vasculitis Associated with Pulmonary Tuberculosis and an Anti-tuberculosis Drug.
    Intern Med. 2024 Feb 19. doi: 10.2169/internalmedicine.3144.
    PubMed        


    J Dermatol

  91. KWON SH, Choi S, Kim JS, Kim SS, et al
    Incidence and survival rates of primary cutaneous malignancies in Korea, 1999-2019: A nationwide population-based study.
    J Dermatol. 2024 Feb 17. doi: 10.1111/1346-8138.17118.
    PubMed         Abstract available

  92. ASAI J, Ohta R, Maruyama A, Katoh N, et al
    Lichen planus pigmentosus successfully treated with topical delgocitinib.
    J Dermatol. 2024 Feb 17. doi: 10.1111/1346-8138.17151.
    PubMed        

  93. OGAYA A, Yamamoto K, Okada E, Sawada Y, et al
    Sclerosing cholangitis exacerbated by widespread pustular psoriasis.
    J Dermatol. 2024 Feb 17. doi: 10.1111/1346-8138.17122.
    PubMed        

  94. YAO Y, Zhu Y, Luo Z, Zhu Y, et al
    Reactive cutaneous capillary endothelial proliferation treated successfully by oral itraconazole: A case report.
    J Dermatol. 2024 Feb 16. doi: 10.1111/1346-8138.17154.
    PubMed        

  95. TAGO M, Koizumi H, Kamiya S, Akashi N, et al
    Panniculitis on the trunk as a possible characteristic feature of anti-SAE1/2 antibody-positive dermatomyositis: A possible cutaneous manifestation of treatment resistance.
    J Dermatol. 2024 Feb 16. doi: 10.1111/1346-8138.17128.
    PubMed        

  96. NAMIKAWA K, Nakano E, Ogata D, Yamazaki N, et al
    Long-term survival with systemic therapy in the last decade: Can melanoma be cured?
    J Dermatol. 2024 Feb 15. doi: 10.1111/1346-8138.17147.
    PubMed         Abstract available

  97. FUJISAWA Y
    Preface to the Journal of Dermatology special issue: The changing landscape of melanoma treatment.
    J Dermatol. 2024 Feb 15. doi: 10.1111/1346-8138.17146.
    PubMed        

  98. XU X, Yu B, Lv Y, Cai Q, et al
    Efficacy and safety of epidural block with lidocaine for refractory severe plaque psoriasis: An open-label pilot study in real world setting.
    J Dermatol. 2024 Feb 13. doi: 10.1111/1346-8138.17145.
    PubMed         Abstract available

  99. YAZDANPARAST T, Nassiri Kashani M, Shamsipour M, Izadi Heidari F, et al
    Contact allergens responsible for eyelid dermatitis in adults.
    J Dermatol. 2024 Feb 13. doi: 10.1111/1346-8138.17140.
    PubMed         Abstract available

  100. YAMAMOTO M, Watanabe Y, Mori T, Iwatsuki K, et al
    Coexistence of pyoderma gangrenosum and cutaneous arteritis without systemic diseases.
    J Dermatol. 2024 Feb 12. doi: 10.1111/1346-8138.17144.
    PubMed        

  101. FURUDATE K, Kato J, Horimoto K, Sato S, et al
    Melanoma incidence on the non-weight-bearing areas of the sole.
    J Dermatol. 2024 Feb 12. doi: 10.1111/1346-8138.17149.
    PubMed        

  102. TSIOGKAS SG, Tsimourtou V, Chaidaki K, Dardiotis E, et al
    Risk of multiple sclerosis in patients with psoriasis receiving anti-IL-17 agents: A case-based review.
    J Dermatol. 2024 Feb 12. doi: 10.1111/1346-8138.17143.
    PubMed         Abstract available

  103. KIM BR, Lee KH, Paik K, Kim M, et al
    Automated mass screening and association rules analysis for comorbidities of psoriasis: A population-based case-control study.
    J Dermatol. 2024 Feb 12. doi: 10.1111/1346-8138.17121.
    PubMed         Abstract available

  104. TOKUYAMA M, Fan P, Wang G, Choe YB, et al
    Epidemiological analysis of the patients with psoriasis in Asian countries and region using the same clinical case cards between 2020 and 2022.
    J Dermatol. 2024 Feb 12. doi: 10.1111/1346-8138.17132.
    PubMed         Abstract available


    J Invest Dermatol

  105. MUKHOPADHYAY S, Brown SJ
    FLG Knockdown-Related Skin-Lung Crosstalk Biologically Underpins an Filaggrin-Related Childhood Asthma Subtype.
    J Invest Dermatol. 2024 Feb 16:S0022-202X(24)00027.
    PubMed        

  106. PYLE HJ, Evans JC, Artami M, Raj P, et al
    Assessment of the Cutaneous Hormone Landscapes and Microbiomes in Vulvar Lichen Sclerosus.
    J Invest Dermatol. 2024 Feb 16:S0022-202X(24)00111.
    PubMed         Abstract available

  107. BIAZUS SOARES G, Hashimoto T, Yosipovitch G
    Atopic Dermatitis Itch: Scratching for an Explanation.
    J Invest Dermatol. 2024 Feb 15:S0022-202X(24)00091.
    PubMed         Abstract available

  108. WONG C, Tham CY, Yang L, Benton MC, et al
    Nanopore sequencing enables allelic phasing of FLG loss-of-function variants, intragenic copy number variation and methylation status in atopic dermatitis and ichthyosis vulgaris.
    J Invest Dermatol. 2024 Feb 7:S0022-202X(24)00097.
    PubMed        

  109. KIM M, Renert-Yuval Y, Stepensky P, Even-Or E, et al
    Sclerotic-type chronic graft-versus-host disease exhibits activation of Th1 and OX40 cytokines.
    J Invest Dermatol. 2023 Sep 22:S0022-202X(23)02595.
    PubMed         Abstract available


    J Laryngol Otol

  110. LAMBOR DV, Shetgaunkar RR, Lambor S, De Sa C, et al
    Novel techniques for prevention of post-operative pharyngocutaneous fistula in locally advanced laryngeal and hypopharyngeal cancers.
    J Laryngol Otol. 2023 Sep 8:1-13. doi: 10.1017/S0022215123001421.
    PubMed        

  111. CASCINO F, Gabriele G, Pulli B, Catarzi L, et al
    Coronavirus disease 2019 pandemic related chondrodermatitis nodularis helicis: the role of masks.
    J Laryngol Otol. 2024;138:276-278.
    PubMed         Abstract available


    Lancet

  112. KRONBICHLER A, Bajema IM, Bruchfeld A, Mastroianni Kirsztajn G, et al
    Diagnosis and management of ANCA-associated vasculitis.
    Lancet. 2024;403:683-698.
    PubMed         Abstract available

  113. KIMBALL AB, Ravichandran S
    Secukinumab treatment of hidradenitis suppurativa: questions remain - Authors' reply.
    Lancet. 2024;403:617-618.
    PubMed        

  114. ENDO M, Kami M
    Secukinumab treatment of hidradenitis suppurativa: questions remain.
    Lancet. 2024;403:617.
    PubMed        

  115. MAUL JT, Kolios AGA, Thomsen SF, Ring HC, et al
    Secukinumab treatment of hidradenitis suppurativa: questions remain.
    Lancet. 2024;403:616-617.
    PubMed        


    Mycoses

  116. DE OLIVEIRA VF, Petrucci JF, Taborda M, Brener PZ, et al
    Clinical characteristics, diagnosis, and treatment of central nervous system sporotrichosis: Systematic review and meta-analysis.
    Mycoses. 2024;67:e13697.
    PubMed         Abstract available

  117. PARIHAR R, Singh U, Das A, Baishya B, et al
    Identification of primary metabolites in fungal species of Trichophyton mentagrophyte and Trichophyton rubrum by NMR spectroscopy.
    Mycoses. 2024;67:e13699.
    PubMed         Abstract available

  118. BALASUBRAMANIAN A, Akbar Ali NA, Pugazhenthi A, Gopalan K, et al
    A clinical prevalence of dermatophytic mycoses with an assessment of its clinical manifestations in a tertiary care hospital at Salem, South India.
    Mycoses. 2024;67:e13707.
    PubMed         Abstract available


    N Engl J Med

  119. CARLSON JCT, Sertic MM, Chen MY
    Case 6-2024: A 21-Year-Old Man with Fatigue and Night Sweats.
    N Engl J Med. 2024;390:747-756.
    PubMed        

  120. MULLER F, Taubmann J, Bucci L, Wilhelm A, et al
    CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-up.
    N Engl J Med. 2024;390:687-700.
    PubMed         Abstract available

  121. KOWDLEY KV, Bowlus CL, Levy C, Akarca US, et al
    Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis.
    N Engl J Med. 2023 Nov 13. doi: 10.1056/NEJMoa2306185.
    PubMed         Abstract available


    Plast Reconstr Surg

  122. BERLI JU, Togioka BM
    Discussion: The Effect of Pectoral Nerve Blocks on Opioid Use and Postoperative Pain in Masculinizing Mastectomy: A Randomized Controlled Trial.
    Plast Reconstr Surg. 2024;153:578-579.
    PubMed        

  123. NIU EF, Amro C, Fischer JP
    Discussion: Relationship between Body Mass Index and Outcomes in Microvascular Abdominally Based Autologous Breast Reconstruction.
    Plast Reconstr Surg. 2024;153:567-568.
    PubMed        

  124. ROCHLIN D, Matros E, Lee C, Sheckter C, et al
    The Financial Impact of S Code Termination for Autologous Breast Reconstruction: Considerations for Patient Access.
    Plast Reconstr Surg. 2024;153:658e-660e.
    PubMed        

  125. SERGESKETTER AR, Langdell HC, Shammas RL, Geng Y, et al
    Efficacy of Prophylactic Postoperative Antibiotics in Tissue Expander-Based Breast Reconstruction: A Propensity Score-Matched Analysis.
    Plast Reconstr Surg. 2024;153:496e-504e.
    PubMed         Abstract available

  126. WALLACE AB, Song S, Yeh P, Kim EA, et al
    The Effect of Pectoral Nerve Blocks on Opioid Use and Postoperative Pain in Masculinizing Mastectomy: A Randomized Controlled Trial.
    Plast Reconstr Surg. 2024;153:570-577.
    PubMed         Abstract available

  127. BAE J, Lee KT, Jeon BJ, Mun GH, et al
    Impact of Initial Filling Medium on Outcomes of Subpectoral, Two-Stage, Implant-Based Breast Reconstruction: Air versus Saline.
    Plast Reconstr Surg. 2024;153:581-589.
    PubMed         Abstract available

  128. EGAN KG, Elver AA, Birney JM, Nazir N, et al
    Autologous Breast Reconstruction Success Rates in Hypercoagulable Patients.
    Plast Reconstr Surg. 2024;153:516e-522e.
    PubMed         Abstract available

  129. HUANG A, Kuchta K, Alva D, Sisco M, et al
    Wise-Pattern Mastectomy with an Inferior Dermal Sling: A Viable Alternative to Elliptical Mastectomy in Prosthetic-Based Breast Reconstruction.
    Plast Reconstr Surg. 2024;153:505e-515e.
    PubMed         Abstract available

  130. BARNES LL, Lem M, Patterson A, Segal R, et al
    Relationship between Body Mass Index and Outcomes in Microvascular Abdominally Based Autologous Breast Reconstruction.
    Plast Reconstr Surg. 2024;153:553-566.
    PubMed         Abstract available

  131. POISSONNET G, Poissonnet V Jr, Dassonville O, Bozec A, et al
    Partial Central Anterior Reconstruction of the Auricle with One-Stage Combined Retroauricular Flaps.
    Plast Reconstr Surg. 2024;153:713-715.
    PubMed         Abstract available

  132. NECKER FN, Cholok DJ, Shaheen MS, Fischer MJ, et al
    Increasing DIEA Perforator Detail in 3D Photorealistic Volume Rendering Visualizations with Skin-masking and Cinematic Anatomy.
    Plast Reconstr Surg. 2024 Feb 14. doi: 10.1097/PRS.0000000000011359.
    PubMed         Abstract available


    PLoS One

  133. LAGO T, Cardoso TM, Rocha A, Carvalho EM, et al
    Short communication: The miR-155a-5p is correlated with increased ROS and impaired apoptosis in macrophages infected by Leishmania braziliensis.
    PLoS One. 2024;19:e0298458.
    PubMed         Abstract available

  134. LU MY, Shobnam N, Livinski AA, Saksena S, et al
    Examining allergy related diseases in Africa: A scoping review protocol.
    PLoS One. 2024;19:e0297949.
    PubMed         Abstract available

  135. KANITTHAMNIYOM C, Wannaphut C, Pattanaprichakul P, Kungwankiattichi S, et al
    Organomegalies as a predictive indicator of leukemia cutis in patients with acute myeloid leukemia.
    PLoS One. 2024;19:e0297805.
    PubMed         Abstract available

  136. SALAIZA-SUAZO N, Porcel-Aranibar R, Caneda-Guzman IC, Ruiz-Remigio A, et al
    Eosinophils of patients with localized and diffuse cutaneous leishmaniasis: Differential response to Leishmania mexicana, with insights into mechanisms of damage inflicted upon the parasites by eosinophils.
    PLoS One. 2024;19:e0296887.
    PubMed         Abstract available

  137. SHIRALKAR J, Anthony T, McCallum GA, Durand DM, et al
    Neural recordings can differentiate between spontaneously metastasizing melanomas and melanomas with low metastatic potential.
    PLoS One. 2024;19:e0297281.
    PubMed         Abstract available

  138. BLANKESPOOR CL, Blankespoor HD, DeJong RJ
    Swimmer's itch control: Timely waterfowl brood relocation significantly reduces an avian schistosome population and human cases on recreational lakes.
    PLoS One. 2024;19:e0288948.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  139. LAUBLI H
    Unraveling the impact of a glyco-immune checkpoint in bone metastasis.
    Proc Natl Acad Sci U S A. 2024;121:e2400499121.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Dermatology is free of charge.